You’re someone’s type

Cozy gift for blood donors during February

Hoxworth wearable blanket

You’re someone’s type, and Hoxworth Blood Center, University of Cincinnati, needs all types to help local patients in need. Donate blood or platelets between February 3 and February 24 and receive a special Hoxworth gift.

For those who donate at any of Hoxworth’s seven Neighborhood Donor Centers or select blood drives, Hoxworth will gift donors with a cozy wearable blanket for contributing to our lifesaving mission. 

Because winter tends to be a difficult period for blood collections across the country, Hoxworth wants to give donors a special February gift.

“Now more than ever, especially with the inclement weather, we need donors to keep their appointments and continue donating to maintain our community blood supply,” says Jackie Marschall, spokesperson for Hoxworth Blood Center. 

To schedule a donation, call Hoxworth at 513-451-0910 or visit www.hoxworth.org. Appointments are highly encouraged.

About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. 

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.